// App-Quantinova.ai

1815 : Management of Secondary Prevention in Venous Thromboembolism: Use of Reduced Doses of Rivaroxaban and Apixaban in Extended Therapy

Researchers

Presenter

  • Desiree Campoy

Principal Investigators

  • Katia Flores

  • Gonzalo Artaza

  • Csar A Velasquez

  • Tania Canals

  • Erik A Johansson

  • Agust Per

  • Jorge Sierra

  • Ramn Salinas

  • Pvel E Olivera

Medical Centers

  • Department of Hematology, University Hospital Sagrat Cor, Barcelona, Spain

  • Banc de Sang i Teixits, Unit of antithrombotic therapy, Barcelona, Spain

  • . Department of Hematology, General University Hospital of Catalonia, Barcelona, Barcelona, Catalonia, Spain

  • Department of Hematology, Fundación Sanitària Mollet, Barcelona, Spain

  • . Department of Hematology, University Hospital Sant Joan de Reus, Tarragona, Tarragona, Catalonia, Spain

  • Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

  • Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • rivaroxaban

  • apixaban

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved